Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.
Proteinase-activated receptor 2: Are common functions in glial and immune cells linked to inflammation-related CNS disorders?
Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.
Low myo-inositol indicating astrocytic damage in a case series of NMO.
Myoinositol trends in different types of brain lesions.
Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis.
Graphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult Brain.
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
Visual outcomes in pediatric optic neuritis.
Elderly-onset neuromyelitis optica spectrum disorders.
Peptide immunotherapy in experimental autoimmune encephalomyelitis.
Progression of Relapsing-Remitting Demyelinating Disease Does Not Require Increased TCR Affinity or Epitope Spread.
Medical management of fecal incontinence in challenging populations: a review.
Comparison of the affective symptomatology between liver transplant recipients and patients with multiple sclerosis considering their functional impairment.
Catatonia and klüver-bucy syndrome in a patient with acute disseminated encephalomyelitis.
Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis.
[Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program) study].
Sodium Correction Practice and Clinical Outcomes in Profound Hyponatremia.
Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelization attacks.
Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population.
Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway.
Development and implementation of microsimulation models of neurological conditions.
Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
Pages
« first
‹ previous
…
662
663
664
665
666
667
668
669
670
…
next ›
last »